Netherlands Pharmaceutical Supply

UK Pharmaceutical Supplier to the Netherlands

The Netherlands sits at the heart of European pharmaceutical logistics. Rotterdam is Europe's largest port and a global pharmaceutical distribution hub, while Amsterdam Schiphol is one of the busiest air cargo gateways on the continent. Dutch healthcare is regulated by CBG-MEB and served by academic medical centres, hospital networks, and a sophisticated importer ecosystem. Euro Biom is an MHRA-licensed UK pharmaceutical supplier that understands the Dutch named patient access programme, CBG-MEB documentation requirements, and the unique position of the Netherlands as a gateway to wider EU pharmaceutical distribution. We hold WDA wholesale dealer authorisation, stock over 5,800 products, and respond same-day to every enquiry from Dutch hospitals, wholesalers, and EU distribution partners.

MHRA WDA(H) 59239, Verified Public Register
GDP Compliant, Cold Chain Certified
Same-Day Response, Every Time
Heathrow to Schiphol, 60 Minutes Direct
The Challenge

Why Dutch Healthcare and Distribution Teams Struggle with UK Pharmaceutical Suppliers

The Netherlands has rigorous pharmaceutical regulation through CBG-MEB and a highly professional importer and distribution ecosystem. Most UK suppliers do not understand CBG-MEB documentation requirements, the Dutch named patient access framework, or the complexity of using the Netherlands as an EU distribution gateway post-Brexit.

CBG-MEB Documentation Standards Are Precise

The College ter Beoordeling van Geneesmiddelen (CBG-MEB) applies specific documentation requirements to pharmaceutical imports. UK suppliers must provide correctly structured CPP, CFS, GMP and GDP records aligned to Dutch regulatory standards. Generic export documentation does not meet the bar that Dutch importers and hospital pharmacies require.

Named Patient Access Programme Requires Specialist Knowledge

Dutch healthcare institutions access unlicensed medicines through the named patient access programme framework. Hospital pharmacists and procurement teams need a UK supplier that understands the supporting documentation required, the sourcing obligations, and the quality chain from UK GMP manufacturer to Dutch patient.

EU Gateway Role Creates Complex Regulatory Requirements

Netherlands-based distributors often source UK medicines for onward supply to other EU markets. This gateway role requires a UK supplier with MHRA documentation that supports EU onward distribution compliance, not just Netherlands import. Most UK wholesalers are not equipped to serve this sophisticated dual-country requirement.

Academic Medical Centre Procurement Is Demanding

Dutch academic medical centres such as AMC Amsterdam, Erasmus MC Rotterdam, and Radboudumc Nijmegen have high documentation and quality standards for pharmaceutical procurement. They need a UK supplier with verified credentials, not just a price list. Most UK exporters cannot meet the evidence requirements these institutions demand.

Shortage Medicines Require a Fast and Verified Supply Chain

The Netherlands experiences pharmaceutical shortages like every EU market. When Dutch hospitals and distributors face shortage situations, they need a UK supplier that can confirm actual stock, dispatch within 24 hours, and deliver verified medicines with complete documentation, not promises and delays.

Post-Brexit Trade Requires Expert Navigation

Post-Brexit pharmaceutical trade between the UK and EU demands additional documentation, regulatory alignment, and supply chain transparency. UK suppliers who have not adapted their processes create customs delays, import rejections, and compliance risk for Dutch buyers. The right UK supplier has invested in getting this right.

The Solution

A UK Pharmaceutical Wholesaler Built for the Netherlands

Pharmaceutical supply to the Netherlands should be reliable, compliant, and built for the professional standards Dutch healthcare and distribution requires. Whether you are sourcing for a named patient access programme, responding to a shortage alert, or using the Netherlands as a gateway for EU distribution, we manage the regulatory complexity from the UK side.

We hold MHRA Wholesale Dealer Authorisation WDA(H) 59239, stock over 5,800 products, and have invested in understanding what CBG-MEB, Dutch hospital pharmacies, and Netherlands-based EU distributors require for pharmaceutical imports from the UK. Documentation is prepared specifically for Dutch and EU regulatory needs from day one.

Based at Heathrow with direct flights to Amsterdam Schiphol in under 60 minutes, we are ideally positioned to supply the Netherlands quickly. For named patient and shortage situations, we respond same-day and dispatch within 24 to 48 hours. For Dutch distribution partners supplying onward into the EU, our MHRA documentation provides the quality assurance chain that EU receiving markets require.

Discuss Your Requirements
MHRA Licence
WDA(H) 59239, Wholesale Dealer Authorisation
MHRA Site Reference
37434242
Regulatory Compliance
UK GDP, CBG-MEB-aligned export documentation
Company Registration
No. 15380737, Registered England and Wales
Base of Operations
Heathrow, London, Direct air freight to Schiphol and Rotterdam
Response Commitment
Same-day response, emergency supply within 4 hours
Why Euro Biom

Why Dutch Healthcare Institutions and Distributors Choose Euro Biom

Practical reasons, not marketing claims. Here is what we do differently for pharmaceutical supply to the Netherlands.

Publicly Verifiable MHRA Licence

WDA(H) 59239 on the MHRA public register. Your procurement team verifies us in 60 seconds. Real credentials, fully transparent, recognised across EU markets and by CBG-MEB-regulated importers.

CBG-MEB-Aligned Export Documentation

CPP, CFS, GMP certificates and GDP chain of custody records prepared to Dutch regulatory standards. Documentation that clears customs and satisfies Dutch hospital pharmacy and importer requirements first time.

EU Gateway Distribution Support

Netherlands-based distributors using Rotterdam and Schiphol as EU distribution hubs receive MHRA documentation that supports onward EU supply compliance. We understand the dual-country requirement that Dutch gateway distributors face.

Named Patient Access Programme Expertise

We support Dutch hospital pharmacists sourcing medicines under the named patient access programme. Documentation aligned to CBG-MEB requirements, with full chain of custody from UK GMP manufacturer to Dutch facility.

We Hold Actual Stock

Over 5,800 pharmaceutical products across 21 therapeutic areas. When we confirm availability for your Dutch order, the medicine is in our warehouse at Heathrow ready for immediate dispatch to Amsterdam or Rotterdam.

Heathrow to Schiphol in Under 60 Minutes

Direct flights from Heathrow to Amsterdam Schiphol with fast ground transport onward to Rotterdam, Utrecht, The Hague and across the Netherlands. Emergency orders arrive within 1 to 2 working days of dispatch.

Cold Chain Integrity Guaranteed

Validated temperature-monitored containers for biologics, vaccines and temperature-sensitive products. Full chain of custody from Heathrow to your Dutch facility, with documentation that meets EU cold chain standards.

Same-Day Response, Every Time

Submit your enquiry by email or phone. Stock confirmation, pricing and delivery timeline returned the same working day. Emergency named patient and shortage cases within 4 hours.

Our Services

Pharmaceutical Supply Services for Dutch Healthcare and Distribution

Four service lines designed around the real procurement and distribution situations that Dutch hospitals, academic medical centres, and EU gateway distributors face when sourcing from the UK.

Service 01

Named Patient Access Programme Supply

Dutch hospital pharmacists sourcing medicines under the named patient access programme need a reliable UK supplier that understands CBG-MEB documentation and quality chain requirements. We source from verified UK GMP manufacturers, prepare supporting evidence, and deliver with complete documentation to Amsterdam, Rotterdam and across the Netherlands.

  • Named patient access programme documentation prepared
  • CBG-MEB-aligned supporting evidence supplied
  • Oncology, rare disease and specialist formulations
  • Same-day response for urgent named patient cases
Service 02

Shortage Medicine Supply

Dutch hospitals and distributors facing shortage situations need a UK supplier that confirms real stock, not promises. We respond same-day to shortage enquiries, dispatch within 24 to 48 hours from Heathrow, and deliver with full GDP documentation. For the Netherlands, Schiphol arrival means medicines can reach any Dutch facility the same or following day.

  • Same-day shortage response and stock confirmation
  • Dispatch within 24 to 48 hours from Heathrow
  • UK-sourced alternatives for unavailable medicines
  • Full CBG-MEB-aligned GDP documentation included
Service 03

Dutch Hospital and Academic Medical Centre Procurement

Academic medical centres and hospital networks in the Netherlands procuring specialist medicines from the UK need verifiable credentials and consistently high documentation quality. We supply branded and generic medicines to AMC Amsterdam, Erasmus MC Rotterdam, and Dutch hospital groups with CBG-MEB-aligned documentation and competitive pricing.

  • Academic medical centre documentation standards met
  • Competitive pricing for hospital networks
  • Oncology, cardiovascular, CNS, immunology supply
  • Regular and repeat order management
Service 04

EU Gateway Distribution via Rotterdam and Schiphol

Netherlands-based pharmaceutical distributors using Rotterdam port or Schiphol air freight for EU supply need a UK wholesale partner whose documentation supports EU onward distribution. We provide MHRA WDA certificates, GDP documentation, and full chain of custody records that satisfy CBG-MEB import requirements and support downstream EU regulatory compliance.

  • MHRA WDA documentation for EU onward distribution
  • Rotterdam and Schiphol logistics compatibility
  • 5,800+ products across 21 therapeutic areas
  • Full GDP chain of custody for EU compliance
Trust and Track Record

Trusted by Pharmaceutical Buyers and Distributors Across the Netherlands

Real procurement teams, real supply challenges. This is what Dutch hospitals, academic medical centres, and distribution partners experience working with an MHRA-licensed UK pharmaceutical supplier.

40+
Countries supplied globally
5,800+
Medicines in active stock
WDA(H)
MHRA Wholesale Dealer Licence
GDP
Good Distribution Practice certified

"We needed a specialist biologic for a named patient case at our Amsterdam facility. Euro Biom sourced it from UK GMP stock, prepared full CBG-MEB-aligned documentation, and had it available within 48 hours. Their named patient process knowledge is genuinely strong."

Hospital Pharmacist
Academic Medical Centre, Amsterdam

"We use Rotterdam as our EU distribution hub and need UK suppliers whose documentation supports our onward EU supply chain. Euro Biom understands this dual-country requirement. Their MHRA WDA paperwork is structured for EU compliance, not just UK export. That distinction matters."

Director of Supply Chain
Pharmaceutical Distributor, Rotterdam

"When a shortage alert hit one of our critical oncology medicines, Euro Biom confirmed UK stock within hours and dispatched from Heathrow the same day. The medicine was in Rotterdam the following morning. That kind of reliable emergency response is exactly what our patients need."

Head of Procurement
Hospital Network, Utrecht
How It Works

How UK Medicine Supply to the Netherlands Works

Simple, transparent, fast. Four steps from your first enquiry to pharmaceutical delivery in Amsterdam, Rotterdam, Utrecht or anywhere across the Netherlands.

1

Submit Your Medicine Enquiry

Product name, strength, form, quantity and urgency. Include whether this is a named patient, shortage, hospital procurement or distribution requirement. Email or call directly. Same-day response, emergencies within 4 hours.

2

Stock Confirmed, Pricing Provided

Definite answer within 24 hours. Availability, price, delivery timeline and documentation scope confirmed in writing. For EU gateway distribution requirements, we confirm which documentation elements are included for onward EU supply.

3

Documentation Prepared for Dutch Requirements

CPP, CFS, GMP certificates, CoA, GDP chain of custody, export invoices and packing lists. All prepared for CBG-MEB requirements. Named patient access programme documentation prepared where needed. EU gateway documentation included for distributor requirements.

4

Dispatched from Heathrow to Schiphol or Rotterdam

Medicines leave our Heathrow facility with cold chain integrity maintained where needed. Tracking provided. Heathrow to Amsterdam Schiphol is approximately 60 minutes direct. Rotterdam is 45 minutes by road from Schiphol. Medicines typically arrive within 1 to 2 working days of dispatch.

Frequently Asked Questions

Questions About Importing Medicines from the UK to the Netherlands

Common questions from Dutch hospitals, academic medical centres, distributors and importers about sourcing UK pharmaceuticals.

Can Euro Biom supply medicines to the Netherlands?
Yes. Euro Biom holds MHRA Wholesale Dealer Authorisation WDA(H) 59239, permitting pharmaceutical exports to licensed healthcare institutions and wholesalers worldwide, including the Netherlands. All exports comply with UK Good Distribution Practice and include CBG-MEB-aligned documentation.
What types of medicines can you supply to the Netherlands?
Branded licensed medicines, generic medicines, named patient access programme medicines, shortage medicines, specialist oncology and rare disease products, cold chain biologics, and wholesale supply for Dutch hospitals, academic medical centres, and EU gateway distributors. Full CBG-MEB-compliant export documentation included.
How quickly can you fulfil orders to the Netherlands?
Urgent named patient and shortage requests receive same-day response with dispatch within 24 to 48 hours. Heathrow to Amsterdam Schiphol is approximately 60 minutes flight time, with Rotterdam 45 minutes by road. Medicines typically arrive within 1 to 2 working days of dispatch. Standard orders typically 5 to 10 working days.
What documentation do you provide for Netherlands pharmaceutical imports?
Complete export package: Certificate of Pharmaceutical Product, Certificate of Free Sale, GMP certificates, Certificate of Analysis, GDP chain of custody documentation, export invoices and packing lists. Documentation aligned to CBG-MEB requirements and Dutch import regulations. EU onward distribution documentation included for distributor requirements.
Can the Netherlands serve as a distribution hub for wider EU supply?
Yes. The Netherlands, particularly Rotterdam as Europe's largest port, is a natural EU pharmaceutical distribution hub. We supply to Netherlands-based distributors and wholesalers who redistribute to other EU markets. Our MHRA WDA documentation supports onward EU distribution compliance.
Can you supply medicines for Dutch hospital procurement?
Yes. We work with Dutch hospitals, academic medical centres, and specialist importers supplying medicines for hospital procurement programmes. Competitive pricing, consistent CBG-MEB-aligned documentation and reliable delivery to Amsterdam, Rotterdam and across the Netherlands.
How do we verify your MHRA licence?
Type WDA(H) 59239 into the MHRA public register at mhra.gov.uk. You will see our licence details, site location at Heathrow, and current authorisation status. The licence is publicly verifiable within seconds and recognised as credible by CBG-MEB-regulated importers.

Ready to Source UK Medicines for the Netherlands?

Send your product list, timeline, or describe the supply challenge. We respond same-day with availability, pricing, and a clear delivery plan to Amsterdam, Rotterdam, Utrecht or anywhere across the Netherlands.

MHRA WDA(H) 59239  ·  Company No. 15380737  ·  Registered England and Wales  ·  work@eurobiom.co.uk